Background: Patient-reported outcomes (PRO) measures relevant to domains most
important to patients with HCC who received locoregional therapies are needed to advance …

Patient‐reported outcomes in HCC: A scoping review by the Pr... : Hepatology Patient‐reported
outcomes in HCC: A scoping review by the Practice Metrics Committee of the American …

Aim: To investigate the association of discordance in patient-and physician-reported
symptoms on health-related quality of life (HRQoL) in hepatocellular carcinoma (HCC) …

Background Incorporating patient reporting of symptomatic adverse events (AEs) is
important in evaluating safety and tolerability in cancer clinical trials. The Patient-Reported …

Comparative effectiveness research aims to create evidence on the efficacy, effectiveness,
benefits and harms of diagnostic and treatment options. Adding patient reported outcomes …

Purpose This study aimed to elucidate the patient experience of hepatocellular carcinoma
(HCC) to guide patient-centered outcome measurement in drug development. Methods …

Background Patients with cancer have reported an unmet need regarding education of all
treatment options available to them and their impact on survival and quality of life (QoL). This …

Patient-reported outcomes (PRO) come directly from a patient about their health condition or
impact of its treatments without interpretation by health care providers. Measures of disease …

The Food and Drug Administration's definition of a patient-reported outcome (PRO) as “any
report of the status of a patient's health condition that comes directly from the patient, without …

Health-related quality of life (HRQoL) measurements are important for patient care, and
emerging bundles in value-based care are placing an increasing emphasis on tying …